Quinoline-Based Hybrid Compounds with Antimalarial Activity

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Infectious Diseases

Background:

• Malaria treatment faces challenges due to increasing drug resistance in quinoline-based antimalarials.
• Combining antimalarials enhances efficacy but is often limited by adverse drug-drug interactions.
• Development of novel antimalarial strategies is crucial to combat resistant malaria strains.

Purpose of the Study:

• To review current research on quinoline-based hybrid compounds for malaria treatment.
• To analyze the preclinical efficacy and potential of these novel hybrid molecules.
• To highlight strategies for overcoming drug resistance and drug-drug interactions in antimalarial therapy.

Main Methods:

• Literature search for studies reporting quinoline-based hybrid compounds.
• Analysis of synthetic routes and chemical functionalities used in hybrid compound preparation.
• Review of preclinical data, including in vitro and in vivo antimalarial activity.

Main Results:

• Hybrid compounds synthesized by linking quinoline moieties with other pharmacophores show promise.
• Preclinical studies indicate enhanced antimalarial activity and potentially reduced resistance compared to parent compounds.
• Hybridization offers a route to circumvent drug-drug interaction limitations.

Conclusions:

• Quinoline-based hybrid compounds represent a viable approach to address antimalarial drug resistance.
• Further preclinical and clinical investigations are warranted to fully evaluate their therapeutic potential.
• Hybridization strategies could lead to next-generation antimalarial drugs with improved safety and efficacy profiles.